If the role of LAT1 in the occurrence and development of insulin resistance is identified, then obesity, T2D, and other diseases associated with insulin resistance may be treated by modifying LAT1 expression or providing LAT1 substrates, such as leucine. The gene discussed is SLC7A5; the disease is obesity due to melanocortin 4 receptor deficiency.